Indication
Prevention of ventricular fibrillation
Prevention of ventricular fibrillation refers to clinical strategies aimed at averting a catastrophic, life-threatening cardiac arrhythmia characterized by rapid, disorganized electrical impulses within the ventricles. Read more about Prevention of ventricular fibrillation
39 drugs 38 manufacturers
Drugs that treat it
Common Prevention of ventricular fibrillation therapies.
AMIODARONE (amiodarone HCl)
AMIODARONE HCL
AMIODARONE HCL
AMIODARONE HCL
PACERONE (amiodarone HCl)
AMIODARONE HCL
AMIODARONE HCL
AMIODARONE HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPrevention of ventricular fibrillation refers to clinical strategies aimed at averting a catastrophic, life-threatening cardiac arrhythmia characterized by rapid, disorganized electrical impulses within the ventricles.
This electrical chaos disrupts coordinated mechanical contraction, causing the lower chambers to fibrillate rather than pump blood, which leads to immediate loss of cardiac output, abrupt hemodynamic collapse, and sudden cardiac death if not promptly terminated.
It primarily affects the cardiovascular system, particularly in individuals with ischemic heart disease, acute myocardial infarction, structural cardiomyopathies, or congenital channelopathies.
Prophylaxis encompasses both primary prevention in vulnerable populations with electrophysiological instability and secondary prevention against recurrence in survivors of previous sustained ventricular tachyarrhythmias.
- nih.gov
Prevention of ventricular fibrillation refers to clinical strategies aimed at averting a catastrophic, life-threatening cardiac arrhythmia characterized by rapid, disorganized electrical impulses within the ventricles This electrical chaos disrupts coordinated mechanical contraction, causing the lower chambers to fibrillate rather than pump blood, which leads to immediate loss of cardiac output, abrupt hemodynamic collapse, and sudden cardiac death if not promptly terminated It primarily affects...
- nih.gov
Prevention of ventricular fibrillation refers to clinical strategies aimed at averting a catastrophic, life-threatening cardiac arrhythmia characterized by rapid, disorganized electrical impulses within the ventricles
- nih.gov
This electrical chaos disrupts coordinated mechanical contraction, causing the lower chambers to fibrillate rather than pump blood, which leads to immediate loss of cardiac output, abrupt hemodynamic collapse, and sudden cardiac death if not promptly terminated
- hopkinsmedicine.org
It primarily affects the cardiovascular system, particularly in individuals with ischemic heart disease, acute myocardial infarction, structural cardiomyopathies, or congenital channelopathies
Personalize your experience
Follow Prevention of ventricular fibrillation and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.